The neuropil surrounding sympathetic preganglionic neurons (SPNs) receives an abundant catecholaminergic innervation originating from the brain stem. The effect of catecholamines (CA) released at this spinal level on the activity of SPNs is still controversial as is the extent to which this particular CA transmission is affected by central antihypertensive drugs, such as clonidine and (Ymethyldopa.
Abstract
The neuropil surrounding sympathetic preganglionic neurons (SPNs) receives an abundant catecholaminergic innervation originating from the brain stem. The effect of catecholamines (CA) released at this spinal level on the activity of SPNs is still controversial as is the extent to which this particular CA transmission is affected by central antihypertensive drugs, such as clonidine and (Ymethyldopa.
The present study was initiated, therefore, to determine the effects of iontophoretic applications of CAs and clonidine on the discharges of identified SPNs and to determine the type of receptor mediating the action of these compounds. Extracellular recordings were made with five-or six-barrel electrodes in 20 pigeons anesthetized with urethane, artificially ventilated, and immobilized. Data were obtained on 83 SPNs localized in the three first thoracic segments and identified on the basis of constancy of antidromic activation latency and collision.
All of the cells sampled were inhibited by the application of low iontophoretic currents of clonidine and by a series of CAs, including Lu-methylnorepinephrine, epinephrine, norepinephrine, and phenylephrine.
For each compound, the amount of charge necessary to decrease the level of cell firing to 50% of control was calculated. Using this value as an index of drug potency, the following rank order could be determined: clonidine > cu-methylnorepinephrine > epinephrine > norepinephrine > phenylephrine.
The inhibitory effects of both clonidine and norepinephrine were antagonized by iontophoretic applications of the (Y antagonists, yohimbine, piperoxan, and phentolamine. In contrast, the p antagonist, sotalol, and the CQ antagonist, prazosin, were found ineffective when similarly applied.
It is concluded that CAs and clonidine are inhibitory to the maintained activity of SPNs and that an az-adrenergic receptor may be involved in the action of these compounds.
Central nervous system (CNS) catecholamine pathways participate in the tonic and phasic modulation of cardiovascular function (Chalmers, 1975; Hauesler, 1977; Loewy and McKellar, 1980; Reis et al., 1977) . However, the exact role of the individual pathways and their mechanism(s) of action are not well defined. This problem is exemplified by the conflicting data surrounding the physiological role of the dense bulbospinal noradrenergic (NE) and adrenergic (E) projections to the sympathetic preganglionic cell column in mammalian as well as avian species (Dahlstrom and Fuxe, 1965; Hokfelt et al., 1974; Zivin et al., 1975; Caserta and Ross, 1978) . Some reports suggest that the NE input to the preganglionic neuropil is excitatory (Neumayr et al., 1974; Taylor and Brody, 1976; Loewy et al., 1979) , while other evidence implies that NE is inhibitory (Coote and MacLeod, 1974, 1977) . Still another hypothesis has been forwarded in which NE and E would have opposite effects, with E being inhibitory and NE being excitatory (Fuxe et al., 1975) . In addition, a limited amount of iontophoretic data is available and indicates that some preganglionic neurons are inhibited by NE but that the majority appear to be unaffected (Hong0 and Ryall, 1966; DeGroat and Ryall, 1967) .
Of some immediate interest is the extent to which these bulbospinal catecholaminergic pathways are affected by centrally acting antihypertensive drugs. One such commonly used agent is clonidine, 2-[ (2,6-dichloro- Schmitt, 1977) . Its hypotensive effects are due primarily to a reduction in sympathetic tone, resulting in decreased peripheral resistance. The exact site(s) of the sympathoinhibitory action of clonidine is poorly understood, though the drug is generally believed to act principally within the medulla (Schmitt, 1977; Kobinger, 1978) . However, there is good evidence for a direct action at the level of the spinal cord as well (Hauesler, 1974; Franz et al., 1978) . Most peripheral and CNS actions of clonidine appear to be due to its interaction with a-adrenergic receptors (Langer et al., 1980) , and indeed, the drug is a partial agonist at (YIadrenergic peripheral (Ruffolo et al., 1979) and central (Rogawski and Aghajanian, 1980) receptors and a very potent agonist at az peripheral presynaptic receptors (Starke, 1977) . The remarkable sympathoinhibitory potency of clonidine and the fact that its effect can be fully reversed by yohimbine, an (Y antagonist with a relative specificity for CX~ receptors at the periphery, suggest the yet undemonstrated possibility that its hypotensive actions could result from an interaction with CNS cuz-like receptors (Schmitt, 1977; Langer et al., 1980) . The presence within the CNS of receptors with properties similar to the (Y~ peripheral presynaptic receptors has been demonstrated recently in the rat locus coeruleus (Cedarbaum and Aghajanian, 1977) and is supported by radioligand binding studies (Miach et al., 1978; Young and Kuhar, 1980) .
The following experiments were initiated to study the effect of clonidine, NE, and other catecholamines on the discharge of sympathetic preganglionic neurons and to determine the nature of the receptors involved in their action at this level.
Materials and Methods

Experimental
animals.
Experiments involved 20 white Carneaux pigeons (Columba Ziuia) ranging in age from 2 to 6 months and weighing 400 to 700 gm. The birds were obtained from the Palmetto Pigeon Plant, Sumter, SC and were treated with antibiotics for 30 days prior to experimentation.
General procedures.
Anesthesia was induced with 15% urethane (1.5 gm/kg, i.p.), after which, the trachea was intubated and positive pressure ventilation was applied at a ratio of 25 to 30/min with a constant tidal volume of 10 ml. The right or left brachial vein was cannulated and birds were immobilized by the intravenous administration of either a single dose of an avian saline solution of a-bungarotoxin (0.2 to 0.5 mg/kg) or pancuronium bromide (1 mg/kg initially with supplemental doses of 0.3 mg/kg as needed). Immobilization drugs were administered over a 20-to 40-min period at a rate of 2.4 ml/hr. For the remainder of the experiment, a 6% dextrose solution was infused continuously (1 to 2 ml/l-u). Body temperature was maintained between 37 and 41°C with a thermostatically controlled heating pad and the EKG (Lead II) was monitored.
Single unit recordings and iontophoresis.
The techniques involved have been described before (Guyenet and Aghajanian, 1978; Guyenet, 1980) ; therefore, only a few details of procedure will be presented. Five-barrel (tip size = 2 pm) or six-barrel glass pipettes were used for extracellular recording and iontophoresis. Six-barrel electrodes consisted of a five-barrel pipette (tip size 2: 10 to 20 pm) glued alongside of a single barrel pipette (tip size = 1 pm), with the latter protruding 25 to 40 pm from the first and used for recording. Six-barrel electrodes were found to provide superior isolation of preganglionic spikes (signal/noise ratio of up to "o/1) and the larger size of the iontophoretic barrels allowed the ejection of drugs of low solubility in water, such as yohimbine and prazosin. (For the manufacture of these electrodes, see Haigler and Aghajanian, 1973; Crossman et al., 1974.) Irrespective of electrode assembly, signal to noise ratios were at least %; in those relatively few instances when action potentials from more than one sympathetic preganglionic neuron (SPN) were recorded simultaneously, the peak-topeak amplitude of the discharge of the SPN chosen to be characterized was greater than twice that of any other background activity.
All recording barrels were filled with a 1% solution of Fast Green in 2 M NaCl (6 to 11 megohms). Signals were amplified lOOO-fold with an AC amplifier (bandpass, 200 to 4000 Hz and 60-Hz notch filter). Spikes then were displayed on an oscilloscope and directed into an electronic counter which was reset automatically every 4, 8, or 16 sec. The output of the counter was fed into a chart recorder which generated the integrated rate histograms shown in Figures 3 and 4 .
For iontophoresis, the following solutions were used at pH 3.5 to 4.5: Z-NE bitartrate (0. , and GABA (y-aminobutyric acid, 0.2 M). Glutamate (0.3 or 0.1 M in 0.1 M NaCl) was prepared at pH 8.4. Automatic current balancing was in effect with five-barrel electrodes; balancing currents were passed through a side barrel filled with 4 M NaCl (20 to 40 megohms). The resistance of all drug-containing channels was 120 to 170 megohms in five-barrel electrodes and 70 to 150 megohms with six-barrel electrodes (except for yohimbine and prazosin which were delivered from 180-to 250-megohm channels). Retaining currents of appropriate polarity were used between ejections (6 to 8 nA with five-barrel electrodes; 10 to 12 nA with sixbarrel electrodes). All drugs were applied at regular intervals to insure the reproducibility of the drug ejections (Bradshaw and Szabadi, 1974) . An index of the potency of inhibitory compounds was obtained using the protocol of DeMontigny and Aghajanian (1977) which is especially useful to compare the potencies of substances apt to produce 100% inhibition of cell firing.
For each drug application, the amount of charge necessary to decrease the discharge rate of the neuron under study by 50% within 20 to 60 set (Qso in nanocoulombs, nC) was determined by multiplying the iontophoretic current used (I in nanoamperes) by the time (7'5',o in seconds) necessary to achieve this 50% inhibition. Given two related agonists having an identical transport num-Vol. 1, No. 8, Aug. 1981 ber, the one with the lower &so will be considered in a first approximation to be the most potent (the assumption of identical transport numbers is not unreasonable when comparing closely related compounds, such as catecholamine derivatives prepared in equimolar concentrations at identical pH).
In the present study, increases in Q50 values have been used as the most sensitive index of drug antagonism. Indeed, during the application of an antagonist, the TAO for a given compound delivered at a constant current increases (Simmonds, 1974; Straughan, 1974) and only when the antagonism is of much larger magnitude does the agonist fail to produce 50% inhibition during the standard ejection time.
Stimulation of sympathetic preganglionic axons. Anatomical and electrophysiological studies in the pigeon (MacDonald and Cohen, 1970; Cohen, 1977b, 1980; Cabot et al., 1979) have established that sympathetic preganglionic neurons (SPNs) in the initial three thoracic spinal segments (segments 15 to 17 in accordance with the terminology of Huber, 1936) give rise to axons which terminate and/or pass through the sympathetic paravertebral ganglion associated with the last cervical spinal segment (G14) (Fig. 1) . In the present experiments, these axons were stimulated with a pair of bipolar, stainless steel (No. 00 insect pins) electrodes which were inserted directly into G14. The electrodes were epoxy-insulated to within 50 to 100 pm of the tips. All experiments were done on the right side.
In order to eliminate any possibility of current spread to the adjacent ventral rootlets, G14 was isolated surgically. Following a dorsal midline incision, the muscles attached along the dorsal and transverse processes of the last cervical and initial four thoracic vertebrae were removed and the vertebral column was fixed in place with stainless steel plates (Cabot and Cohen, 1977a) . A laminectomy was performed, exposing dorsal root ganglion 14, its rootlets, the ventral roots of this spinal segment, and G14. Subsequently, the dorsal and ventral roots were cut. Since G14 contains the majority of sympathetic cardiac postganglionic neurons (MacDonald and Cohen, 1970; Cabot and Cohen, 1977a) , the placement of the stimulating electrodes was judged to be optimal if a stimulus train of 10 to 20 pulses (0.5 msec pulse duration, 25 Hz, 25 to 50 fi current intensity) elicited a marked, short latency cardioacceleration. Mechanical damage to preganglionic axons was apparently minimized by this placement as these axons exhibited low thresholds for activation with single, constant current pulses (0.5 msec duration, 25 to 150 PA current intensity).
Identification of sympathetic preganglionic neurons. After the isolation of G14, a laminectomy was performed between the first and third thoracic spinal segments (Tl to T3). Since the avian thoracolumbar preganglionic cell Figure 1 . Schematic diagram of the experimental preparation. Note the location of avian sympathetic preganglionic neurons (SPNs) and the isolation of sympathetic ganglion 14 (G14). Tl, first thoracic spinal segment. (Terni, 1923; MacDonald and Cohen, 1970; Cohen, 1977b, 1980) , the most effective trajectory for recording microelectrodes involved a dorsal midline approach. In order to do this, however, the blood sinus located on the dorsal surface of the spinal cord had to be cauterized carefully in the restricted region of Tl to T3 where recording was to begin. Additional areas were cauterized as necessary in any given experiment. After the local removal of the blood sinus, small openings in the dural and pial membranes were made with a 26 gauge needle. The above protocol often resulted in the minor herniation of the dorsal funiculus (right side only). The exposed spinal cord and G14 were covered with a warmed mixture of mineral oil and petroleum jelly (41°C). Electrophysiological criteria for the identification of SPNs included (i) constancy of antidromic activation latency and (ii) the collision of an orthodromically conducted action potential with that of an antidromically elicited action potential (Darian-Smith et al., 1963) . Both criteria were satisfied for every cell reported in this study prior to any evaluation of their pharmacological sensitivity to iontophoretically applied drugs.
The recording electrode barrel in all experiments contained a 2 M NaCl, 1% Fast Green solution. In four experiments spaced throughout the total series of 20, a Fast Green dye spot was deposited at the recording site of a SPN which had been characterized pharmacologically (DC cathodal current, 20 I-IA, 20 min duration). At the end of these experiments, the birds were perfused with 10% formalin and the spinal cord segment containing the recording site was removed. Serial 30-pm sections were cut frozen, mounted on slides, air dried, and counterstained with cresyl violet acetate.
Results
Identification
and general properties of SPNs. Avian SPNs are localized dorsal and dorsolateral to the central canal at Tl to T3 spinal levels. It should be appreciated that, despite this midline locus, the preganglionic cell column is a paired nucleus and all of the available evidence shows that there are no cross-projections. As noted under "Materials and Methods," cells were identified as being SPNs if (i) the onset latency of an antidromically evoked discharge remained constant at threshold (T) and 2 x T current intensities for activation and (ii) the requirements of the collision test were satisfied (Fig. 2) . SPNs meeting these criteria were found exclusively to the right of and within 150 pm of the midline (i.e., ipsilateral to the site of preganglionic axon stimulation), at depths of approximately 500 to 1000 pm from the dorsal surface of the spinal cord, and throughout Tl, T2, and rostra1 T3 spinal segments, though most of the recordings were from cells localized within caudal Tl and rostra1 T2. Additionally, in the four experiments in which Fast Green was deposited at the recording site of a SPN, histological recovery of the dye spots revealed that all such marks were to the right of the midline and within the cytoarchitectonically defined boundaries of the sympathetic preganglionic cell column.
Generally, the conformation of the extracellularly re- corded action potentials of SPNs differed depending upon the electrode assembly used. In experiments where five-barrel electrodes were utilized, the potentials were predominantly biphasic, negative-positive; small preceding-and/or after-positivities were noted sometimes. The extracellular potentials recorded with six-barrel electrodes were usually triphasic, positive-negative-positive; frequently a prominent after-positivity was present as well. The observed peak-to-peak amplitude voltage ranged from 0.4 to 0.6 mV with five-barrel electrodes and from 0.5 to 5.0 mV with six-barrel electrodes. Regardless of the electrode. assembly used, stable recordings for periods of 15 to 30 min were common. However, the use of six-barrel electrodes allowed longer term observations and often the discharge of a SPN could be isolated for 1 to 2 hr.
By requiring that the collision test be satisfied for all neurons, the present sample is biased toward that minority of SPNs showing maintained activity. While the actual number of ceils without spontaneous activity was not tabulated systemically, a conservative estimate would be that over 80% of the SPNs at Tl to T3 spinal levels are silent under the present experimental conditions. The sample is biased in yet another way; SPNs with irregular discharge rates of less than 0.5 spike/set were encountered sometimes but were not characterized pharmacologically because of difficulties experienced in establishing reliable base line levels of activity.
Given these limitations, the SPNs studied exhibited onset latencies of antidromic activation ranging from 2 912 Guyenet and Cabot Vol. 1, No. 8, Aug. 1981 to 43 msec (Fig. 2) . These latencies suggest that avian preganglionic axons conduct at 0.4 to 5.6 meters/set (the distances between the stimulating and recording electrodes were estimated to be 7 to 15 mm). This conduction velocity range compares well with previous estimates in the pigeon (Cabot and Cohen, 1980) and is similar to that reported in mammals (Fernandez de Molina et al., 1965; Polosa, 1967; Taylor and Gebber, 1973; McLachlan and Hirst, 1980) . The average antidromic activation latency was 9.5 + 7.8 msec (mean f SD, n = 83 cells); the median latency was 6.5 msec. There were no systematic differences associated with the type of recording electrode assembly.
The maintained activity of SPNs ranged from 0.1 to 13.0 spikes/set.
The average firing frequency was 3.2 f 2.6 spikes/set (n = 73 cells); the median activity was 2.7 spikes/set.
Again, there were no significant differences associated with the type of electrode assembly used. Moreover, there was no apparent correlation between discharge rate and the onset latency for antidromic activation.
Inhibitory effects of clonidine and catecholamines on SPN single unit activity. Clonidine, a-methyl-NE, epinephrine, NE, and phenylephrine inhibited the firing rate of all SPNs tested irrespective of the type of iontophoretic electrode used (Figs. 3 and 4 and Table I ). The cells responded to iontophoretic currents of increasing intensity first by an increase in the maximum level of inhibition, which eventually reached 100% with the vast majority of the cells, and secondly by shortening the time necessary to achieve 100% inhibition (Fig. 3B) . The amplitude and shape of the action potentials were usually unaltered by either clonidine or catecholamines although, occasionally, a slight amplitude increase was observed during the period of application and during the recovery phase. During periods of total inhibition, no change either in the latency, size, and shape of antidromically elicited spikes or in the threshold currents necessary to elicit these discharges was noted (a slight increase in the amplitude of antidromic spikes was observed again). The inhibition of cell discharges caused by the iontophoretic applications of clonidine and catecholamines was fully reversible and unaltered with repeated applications (up to 20 times in the case of NE, up to 6 times in the case of clonidine). Recovery from the inhibitory effect of catecholamines was moderately rapid (12 to 40 set, Fig. 3 , A to F) while that from clonidine was invariably slow (2 to 10 min, Figs. 30 and 4, A to C) . The inhibition resulting from the delivery of comparable currents of GABA completely recovered within 4 to 8 set following the end of the drug application (Fig. 3A) . These observations were consistent independent of the electrode assembly used. A description of the number of cells sampled, iontophoretic currents, and ejections times used is presented in summary form in Table I .
The amount of charge necessary to decrease the neuronal firing rate by 50% (QsO = TAO x 4 I in nanoamperes, Tw in seconds, Q in nanocoulombs) was reproducible across pipettes and cells and characteristic of a particular amine when determined with the same type of electrode (five-or six-barrel).
The Qr,o values determined with sixbarrel electrodes were larger and more variable than those measured with five-barrel electrodes; this certainly can be attributed to the geometry of the six-barrel electrodes and the fact that, in these electrodes, the iontophoretic barrels were further away from the recording electrode (25 to 40 pm). Clonidine was applied using either a standard 0.1 M solution or a 20 mM solution diluted in 160 mM NaCl; the dilution of the drug resulted in an approximately 3-fold increase in the corresponding Q50 values. As indicated in Table I, the Q50 values for  clonidine and catecholamines as determined with five- Among the 83 cells presented in this study, 9 were initially silent and the effects of NE (6 cells) and clonidine (3 cells) were tested while the neurons were made to discharge at a constant slow rate (1.5 to 3 spikes/set) by continually applying very small currents of glutamate (0 nA or leak to 12 nA). The effects of NE and clonidine on the cells' firing rate were quantitatively identical to that Table I. A number of silent units also were encountered which could be activated transiently by ejecting rather large currents of glutamate (50 nA to eject reliably drugs of low solubility in water, such as yohimbine and prazosin.
The LYZ antagonists, piperoxan (6 to 15 nA, 10 to 20 min) and yohimbine (10 to 25 nA, 10 to 20 min), increased significantly and reversibly the Qx, values for the inhibition of SPN activity by NE (Fig. 4, A, B , and C and Table II ). Neither piperoxan nor yohimbine had any action on the inhibitory effects of GABA (3 cells tested with each antagonist). The broad spectrum LY antagonist, phentolamine (13 to 25 nA, 15 min), also antagonized the inhibitory effect of NE in all 6 cells tested (Fig. 40) . However, in 5 out of the 6 cells, the antagonism by phentolamine was less marked than in the example shown in Figure 4 . Moreover, signs of local anesthetic effects (spike broadening, decrease in amplitude, dissociation of presumed initial segment, and somadendritic components) were noted in four cases after 10 min of iontophoretic phentolamine.
The p antagonist, sotalol (25 nA, up to 20 min, 4 cells tested; Fig. 4E ), and the (~1 antagonist, prazosin (30 n4, up to 20 min, 5 cells tested), failed to produce any detectable change in the &50 values for NE. These two compounds did not produce any local anesthetic effects in the doses used.
Yohimbine (10 to 25 nA, 10 to 20 min, 5 cells) and piperoxan (6 to 15 nA, 10 to 20 min, 4 cells) antagonized the inhibitory effect of clonidine (Fig. 4, A, B, and C) . Both compounds also could restore the firing rate of a neuron inhibited by a prior application of clonidine (Fig.  4B) . Piperoxan appeared to antagonize more completely the inhibitory effect of clonidine than that of NE in all 3 cells where antagonism to both compounds could be tested simultaneously (Fig. 4, A and B) and the same result was observed with yohimbine in 3 cells (Fig. 4C) . It should be noted, however, that strictly equiefficacious doses of NE and clonidine may not have been delivered in these instances.
Finally, in 4 cells, NE also was applied during the recovery phase from a prior clonidine application to determine whether the latter compound might antagonize the inhibitory effect of NE and thus exhibit properties of a partial antagonist. No indication of a decreased n In these cases, the agonist failed to produce 50% inhibition of the cell's discharge rate by the end of the standard ejection time in the presence of the antagonists. effect of NE was found in any of these cases (Fig. 4, B and C).
Discussion
The results of the present study indicate that iontophoretically applied catecholamines and clonidine uniformly inhibit the spontaneous firing of SPNs. Thus, in agreement with several previous authors (DeGroat and Ryall, 1967; Coote and MacLeod, 1977; Hongo and Ryall, 1966) , it seems reasonable to conclude that at least one of the physiological effects of endogenously released catecholamines within the SPN neuropil is to inhibit the discharge rate of SPNs.
The usefulness of the &so values as an index of drug potency, as well as their validity to evaluate drug antagonism, has been documented previously in various iontophoretic studies (Simmonds, 1974; Wang et al., 1979) . QsO values can be used to determine the rank order of potency of several agonists only if the transport number for these agents is identical. In the case of equimolar solutions of chemically related drugs, such as the various catecholamines used in this study, the hypothesis of identical transport numbers can be reasonably assumed. From the respective &so values of a-methyl-NE, E, and NE determined with five-barrel electrodes (Table I) , it can be suggested, therefore, that the relative potency of these compounds lies in the above order. The fact that a-methyl-NE is significantly more potent than NE is of potential interest as it provides supporting evidence for an often proposed but unverified hypothesis regarding the mechanism of the central antihypertensive action of a-methyldopa (Langer et al., 1980) . It is amply documented that this centrally active drug has to be converted by noradrenergic or adrenergic terminals into cu-methyl-NE or cY-methylepinephrine in order to exert its hypotensive action (Henning and Rubenson, 1971; Van Zwieten, 1980) . Therefore, these two catecholamines were supposed to act as false neurotransmitters. The present data suggest that the antihypertensive action of cu-methyldopa could be explained in part by the fact that a-methyl-NE is released at the level of the SPNs in place of NE but produces an inhibition of these neurons in excess of that resulting from the release of the physiological transmitter.
As indicated in Table I (five-barrel electrodes), the QM values for clonidine-induced inhibition were lower than those for all of the catecholamines tested when the antihypertensive drug was used in equimolar concentration with that of the amines. Again, given the assumption of equal transport numbers, this result suggests that clonidine may be more potent than norepinephrine or epinephrine in inhibiting the discharge rate of SPNs. When a solution of clonidine in NaCl was used for iontophoresis, the observed &SO values for inhibition were increased substantially as might be expected from a reduction in the transport number of the active compound. Recovery from clonidine-induced inhibition was extremely slow in comparison to that following applications of catecholamines. This fact can probably be accounted for by differences in uptake and catabolism.
The determination of the relative potencies of pharmacological agents using six-barrel electrodes was inconclusive. Indeed, the differences in Qm values between clonidine, a-methyl-NE, E, and NE that were clearly apparent with five-barrel electrodes were not evident when averaged across pipettes; this is due in large part to an increased dispersion of the observed QsO values but perhaps also to the fact that the potency of the drug may play a somewhat reduced role in the kinetics of the cell response when the active compound is delivered 30 to 40 pm away from the cell body. In this situation, other factors, such as diffusion, binding, uptake, and liposolubility, may become significant in determining how fast the cell is inhibited unless very large differences in potency or efficacy exist. Such an important difference in potency was demonstrated in the case of phenylephrine when compared with other catecholamines (Table I) . In summary, the weights of the combined evidence lead to the proposal that the relative order of potency for clonidine and all of the other amines tested in the present study was: clonidine > a-methyl-NE > E > NE z+ phenylephrine.
This rank order suggests the possibility that an (~2 receptor may be involved in mediating the effect of catecholamines. However, because of the difficulties associated with the determination of relative potencies using the technique of iontophoresis, the most pertinent discussion of the present findings derives from comparing 916 Guyenet and Cabot Vol. 1, No. 8, Aug. 1981 the Kobinger, 1978; Laubie and Schmitt, 1977) . The possibility of a direct action of the drug at the level of the preganglionic cell column in the cat has been suggested by Franz et al. (1978) and Madsen et al. (1980) although additional spinal sites may also exist (Dembrowsky et al., 1980 
